Description
AFP, HCG and Free Estriol 14-22 weeks
Sample Type:Serum
Tests Included:
In the context of pregnancy, the Triple Test typically includes measurements of alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and unconjugated estriol (uE3).
Sample Required:
Blood sample collection for this test.
Test Time:
Results are usually available within a few days after sample collection.
What is 
the test?
The Triple Test in pregnancy assesses the risk of Down syndrome and other chromosomal abnormalities by measuring specific proteins and hormones in the maternal blood.
Test Procedure:
Blood is drawn from the pregnant individual, and the levels of AFP, hCG, and uE3 are measured in the laboratory.
When to take the test:
Recommended between weeks 15 and 20 of pregnancy for Down syndrome screening.
Who should take t
he test:
Pregnant individuals, especially those at higher risk or with specific concerns about fetal chromosomal abnormalities, might consider this test.
Precauti
ons for exceptional cases (pregnancy, etc.):
The Triple Test is a screening test and might not provide a definitive diagnosis. Additional tests like genetic counseling or invasive diagnostic tests might be recommended based on the results.
Frequently Asked Questions (FAQs) for Triple Test in Pregnancy:
Q1: Can the Triple Test provide a definitive diagnosis for Down syndrome?
A: No, the Triple Test is a screening test that estimates the risk of Down syndrome and other chromosomal abnormalities. Further invasive tests might be necessary for a definitive diagnosis.
Q2: What does a high or low Triple Test result indicate?
A: Abnormal levels in the Triple Test might indicate an increased risk for chromosomal abnormalities, but further testing is required for confirmation.
Q3: Can factors like maternal age affect Triple Test results?
A: Yes, maternal age is a factor considered in interpreting Triple Test results, as advanced maternal age increases the risk of chromosomal abnormalities.
Q4: Is the Triple Test mandatory during pregnancy?
A: The Triple Test is optional and considered in pregnancies where individuals want information about the risk of chromosomal abnormalities.
Q5: Are there risks associated with the Triple Test?
A: The Triple Test is a non-invasive screening test and generally poses no risks to the pregnancy or the fetus.
*Please note that specific testing protocols and guidelines may vary based on the latest recommendations from health authorities and regulatory agencies. It is essential to consult healthcare professionals and follow local testing guidelines for accurate and appropriate testing.
